Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 401–500 of 1,001
Adamo, M., Pagnesi, M., Rubbio, A. P., Branca, L., Grasso, C., Denti, P., Giordano, A., Tusa, M. B., MARCO, F. D., Lupi, L., et al. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30062 · Cited by 32
Hafkamp, F. J., Tio, R. A., Otterspoor, L., Greef, T. V.-D., van Steenbergen, G. J., van de Ven, A. R. T., Smits, G., Post, H., & van Veghel, D. (2022) · Heart Failure Reviews · doi:10.1007/s10741-021-10212-8 · Cited by 32
Shechter, A., Vaturi, M., Kaewkes, D., Koren, O., Koseki, K., Solanki, A., Natanzon, S. S., Patel, V., Skaf, S., Makar, M. M., et al. (2023) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.12.026 · Cited by 32
Hautmann, M. B., Zacher, M., Fuchs, S., Pérez, C. M., Ahmidou, A., Kerber, S., & Barth, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-27622-3 · Cited by 32
Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation
Arnold, S. V., Spertus, J. A., GOSCH, K. L., Dunlay, S. M., Olds, D. M., Jones, P. G., Bocell, F. D., Wu, C., & Cohen, D. J. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.4266 · Cited by 32
Self-citationBuzzatti, N., Denti, P., Scarfò, I. S., Giambuzzi, I., Schiavi, D., Ruggeri, S., Castiglioni, A., Bonis, M. D., Canna, G. L., & Alfieri, O. (2018) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28029 · Cited by 32
“This discrepancy is likely to be mostly due to the different patient selection in the two studies, the biggest survival benefit being observed in patients with more severe MR, less severe left ventricular volume remodeling and truly optimized medical therapy.(13,14) Similar to these studies, in our series survival of…”
ResultStatistical Appraisal of 6 Recent Clinical Trials in Cardiology
Pocock, S., & Collier, T. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.484 · Cited by 32
Zhang, Y., Wang, V. Y., Morgan, A. E., Kim, J. J., Handschumacher, M. D., Moskowitz, C. S., Levine, R. A., Ge, L., Guccione, J. M., Weinsaft, J. W., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223472 · Cited by 32
“[5]”
Cheng, R., Dawkins, S., Hamilton, M. A., Makar, M. M., Hussaini, A., Azarbal, B., Patel, J. K., KOBASHIGAWA, J. A., Trento, A., Makkar, R., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.05.042 · Cited by 32
Self-citationTranscatheter Mitral Valve Replacement for Severe Mitral Annular Calcification
Sorajja, P., Thourani, V. H., Rogers, J. H., Bethea, B. T., Guerrero, M. E., Lim, D. S., Hebeler, R. F., Cowger, J. A., Allen, K. B., Sharma, R. P., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.10.025 · Cited by 31
Self-citationMachine Learning in Cardiology—Ensuring Clinical Impact Lives Up to the Hype
Russak, A. J., Chaudhry, F., Freitas, J. K. D., Baron, G., Chaudhry, F. F., Bienstock, S., Paranjpe, I., Vaid, A., Ali, M., Zhao, S., et al. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420928651 · Cited by 31
“These techniques, including transcatheter aortic valve replacement (TAVR) 3,34,35 and transcatheter mitral valve repair, 36 have significantly increased access to care for previously ineligible patients while simultaneously reducing morbidity and mortality for thousands of individuals.”
MethodBELLE, E. V., Teles, R. C., Pyxaras, S. A., Kalpak, O., Johnson, T., Barbash, I. M., Luca, G. D., Kostov, J., Parma, R., Vincent, F., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-18-00448 · Cited by 31
Natural Course of Nonsevere Secondary Tricuspid Regurgitation
Spinka, G., Bartko, P. E., Heitzinger, G., Prausmüller, S., Pávó, N., Frey, M. K., Arfsten, H., Genger, M., Hengstenberg, C., Hülsmann, M., et al. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2020.08.018 · Cited by 31
Bayés‐Genís, A., Aimo, A., Metra, M., Anker, S. D., Seferovic, P. M., Rapezzi, C., Castiglione, V., Núñez, J. E., Emdin, M., Rosano, G. M. C., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2542 · Cited by 31
Hemodynamic Profiles and Clinical Response to Transcatheter Mitral Repair
Sato, H., Cavalcante, J. L., Bae, R. Y., Enriquez-Sarano, M. L., Bapat, V., Gössl, M., Fukui, M., & Sorajja, P. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.06.020 · Cited by 31
Donà, C., Nitsche, C., Koschutnik, M., Heitzinger, G., Mascherbauer, K., Kammerlander, A. A., Dannenberg, V., Halavina, K., Rettl, R., Duca, F., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.06.009 · Cited by 31
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement
Schneider, L., Worthley, S. G., Nickenig, G., Huczek, Z., Wojakowski, W., Tchétché, D., Dubois, C., Nasr, M., Verhees, L., Rothman, M. T., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.09.003 · Cited by 31
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy, M., & Maisano, F. (2024) · EuroIntervention · doi:10.4244/eij-d-23-00700 · Cited by 31
Gómez‐Mesa, J. E., Saldarriaga, C., Jurado-Arenales, A. M., Mariño, A., Rivera, A., Herrera, Á., Buitrago, A. F., Peña, Á. A. G., Figueredo, A., Rivera, E. L., et al. (2019) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.06.001 · Cited by 31
Surgical revision of failed percutaneous edge-to-edge mitral valve repair: lessons learned
Takayuki, G., Schenk, S., Rochor, K., Harnath, A., Grimmig, O., Just, S. R., & Fritzsche, D. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy361 · Cited by 30
Valvular heart disease in patients with chronic kidney disease
Hoevelmann, J., Mahfoud, F., Lauder, L., Scheller, B., Böhm, M., & Ewen, S. (2021) · Herz · doi:10.1007/s00059-020-05011-0 · Cited by 30
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification
Fernández‐Peregrina, E., Pascual, I., Freixa, X., Tirado‐Conte, G., Estévez‐Loureiro, R., Carrasco-Chinchilla, F., Benito‐González, T., Asmarats, L., Sanchís, L., Jiménez-Quevedo, P., et al. (2022) · EuroIntervention · doi:10.4244/eij-d-21-00205 · Cited by 30
Scotti, A., Latib, A., Rubbio, A. P., Testa, L., Adamo, M., Denti, P., Melillo, F., Taramasso, M., Sisinni, A., MARCO, F. D., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.10.024 · Cited by 30
Miura, M., Yamaji, K., Shirai, S., Hayashi, M., Kawaguchi, T., Arai, Y., Sakaguchi, G., Andò, K., Naganuma, T., Mizutani, K., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.12.022 · Cited by 30
Lerakis, S., Kini, A. S., Asch, F. M., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Grayburn, P. A., Weissman, N. J., Rinaldi, M., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-20-01265 · Cited by 30
Self-citationKriechbaum, S. D., Boeder, N., Gaede, L., Arnold, M. B., Vigelius-Rauch, U., Roth, P., Sander, M., Böning, A., Bayer, M., Elsässer, A., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01538-3 · Cited by 29
“Transcatheter leaflet repair has demonstrated reduction in severe MR but is typically accompanied by an elevated transvalvular systolic gradient [13, 14, 18].”
BackgroundMethodHagendorff, A., Knebel, F., Helfen, A., Stöbe, S., Doenst, T., & Falk, V. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01975-6 · Cited by 29
Oğuz, D., Padang, R., Rashedi, N., Pislaru, S. V., Nkomo, V. T., Mankad, S. V., Malouf, J. F., Guerrero, M. E., Reeder, G. S., Eleid, M. F., et al. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.01.018 · Cited by 29
Ooms, J. F., Bouwmeester, S., Debonnaire, P., Nasser, R., Voigt, J., Schotborgh, M. A., Geleijnse, M. L., Kardys, I., Spitzer, E., Daemen, J., et al. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.08.002 · Cited by 29
Rubbio, A. P., Testa, L., Granata, G., Salvatore, T., MARCO, F. D., Casenghi, M., Guerrini, M., Oliva, O., Stefanini, E., Barletta, M., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30044 · Cited by 29
CT in Transcatheter-delivered Treatment of Valvular Heart Disease
Rudziński, P. N., Leipsic, J. A., Schoepf, U. J., Dudek, D., Schwarz, F., Andreas, M., Złahoda-Huzior, A., Thilo, C., Renker, M., Burt, J. R., et al. (2022) · Radiology · doi:10.1148/radiol.210567 · Cited by 29
National Institute for Health and Care Excellence (NICE) guidance on heart valve disease
Shah, B. N. (2023) · Heart · doi:10.1136/heartjnl-2022-321095 · Cited by 29
Fraccaro, C., Karam, N., Möllmann, H., Bleiziffer, S., Bonaros, N. E., Teles, R. C., Ferreira, P. C., Chieffo, A., Czerny, M., Donal, E., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-23-00473 · Cited by 29
Asgar, A., Tang, G. H. L., Rogers, J. H., Rottbauer, W., Morse, M. A., Denti, P., Mahoney, P., Rinaldi, M., Asch, F. M., Zamorano, J. L., et al. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.08.001 · Cited by 31
Self-citationPascual, I., Arzamendi, D., Carrasco‐Chinchilla, F., Fernández‐Vázquez, F., Freixa, X., y, L. N.-F., y, P. A., Frutos, A. S., Pan, M., Álvarez, A. B. C., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.014 · Cited by 29
Numerical Simulations of MitraClip Placement: Clinical Implications
Kamakoti, R., Dabiri, Y., Wang, D. D., Guccione, J. M., & Kassab, G. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52342-y · Cited by 29
Howsmon, D. P., Rego, B. V., Castillero, E., Ayoub, S., Khalighi, A. H., Gorman, R. C., Gorman, J. H., Ferrari, G. M., & Sacks, M. S. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0098 · Cited by 29
“Newer, less invasive surgical techniques, such as the MitraClip, promise to address both the safety of the procedure and the IMR recurrence rate [14].”
BackgroundTayal, B., Debs, D., Nabi, F., Malahfji, M., Little, S. H., Reardon, M. J., Zoghbi, W. A., Kleiman, N. S., & Shah, D. J. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.004 · Cited by 29
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II
Blacher, M., Zimerman, A., Engster, P. H. D. B., Grespan, E., Polanczyk, C. A., Rover, M. M., Neto, J. A. D. F., Danzmann, L. C., Bertoldi, E. G., Simões, M. V., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317984 · Cited by 29
Combining Life and Health Insurance*
Koijen, R. S. J., & Nieuwerburgh, S. V. (2019) · The Quarterly Journal of Economics · doi:10.1093/qje/qjz037 · Cited by 29
“all-cause mortality in the 24 months after the device is implanted (Stone et al., 2018).”
Alshawabkeh, L. I., Mahmud, E., & Reeves, R. R. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29238 · Cited by 28
Ojeda, S., Romaguera, R., Cruz‐González, I., & Moreno, R. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.09.005 · Cited by 28
“The fall in readmissions due to heart failure and mortality documented in the COAPT study—maintained at 3 years—have reinforced the use of this technique, 43 which additionally permits the identification of the ideal candidates for this approach.”
MethodScotti, A., Munafò, A., Adamo, M., Taramasso, M., Denti, P., Sisinni, A., Buzzatti, N., Stella, S., Ancona, F., Zaccone, G., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.12.003 · Cited by 23
Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation
Tanaka, T., Sugiura, A., Vogelhuber, J., Öztürk, C., Böhm, L., Wilde, N., Zimmer, S., Nickenig, G., & Weber, M. (2024) · EuroIntervention · doi:10.4244/eij-d-23-00819 · Cited by 28
“The COAPT trial, a randomised control trial comparing TEER with medical therapy, has revealed the prognostic benefit of TEER in VFMR patients 7 ; however, evidence regarding the prognostic impact of TEER for patients with AFMR is still limited.”
Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure
Pio, S. M., Medvedofsky, D. A., Delgado, V., Stassen, J., Weissman, N. J., Grayburn, P. A., Kar, S., Lim, D. S., Redfors, B., Snyder, C., et al. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.03.016 · Cited by 28
Self-citationHFSA Scientific Statement: Update on Device Based Therapies in Heart Failure
Estep, J. D., Salah, H. M., Kapadia, S. R., Burkhoff, D., Lala, A., Butler, J., Hall, S. A., & Fudim, M. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.07.007 · Cited by 28
Self-citationContemporary Management of Heart Failure in the Elderly
Osmanska, J., & Jhund, P. S. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0625-4 · Cited by 28
Percutaneous Mitral Edge-to-Edge Repair: State of the Art and a Glimpse to the Future
Khan, F., Winkel, M., Ong, G., Brugger, N., Pilgrim, T., Windecker, S., Praz, F., & Fam, N. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00122 · Cited by 28
“Surgical treatment of secondary MR is not well established, therefore the recently published results of the randomized MITRA-FR and COAPT trials examining the additive benefits of MC on top of medical therapy specifically in secondary MR populations were highly anticipated (4, 5).”
MethodResultClinical impact of post procedural mitral regurgitation after transcatheter aortic valve replacement
Ben–Assa, E., Biner, S., Banai, S., Arbel, Y., Laufer‐Perl, M., Kramarz, J., Elmariah, S., Inglessis, I., Keren, G., Finkelstein, A., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.092 · Cited by 28
Stroke after transcatheter edge-to-edge mitral valve repair: a systematic review and meta-analysis
da Silva, P. B., Sousa, J. P., Oliveiros, B., Donato, H., Costa, M. A. D. S., Gonçalves, L. M. M., & Teixeira, R. P. (2020) · EuroIntervention · doi:10.4244/eij-d-19-00602 · Cited by 29
Gyoten, T., Schenk, S., Rochor, K., Herwig, V., Harnath, A., Grimmig, O., Just, S. R., Fritzsche, D., & Messroghli, D. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12741 · Cited by 28
“6% (defined as post-operative MR grade ≦ 2), the functional results of pMVR in our cohort were better than those recently reported in the MITRA-FR and COAPT trials.(14,20) Peri-”
BackgroundResultInfluentialSannino, A., Sudhakaran, S., Milligan, G. P., Chowdhury, A., Haq, A., Szerlip, M., Packer, M., & Grayburn, P. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.079 · Cited by 28
Self-citationJolley, M. A., Sulentic, A., Amin, S., Gupta, M., Ching, S., Cianciulli, A. R., Wang, Y., Sabin, P., Zelonis, C. N., Daemer, M., et al. (2023) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30935 · Cited by 27
Current Antithrombotic Treatments for Cardiovascular Diseases: A Comprehensive Review
Galanti, K., Marino, M. D., Mansour, D., Testa, S., Rossi, D., Scollo, C., Magnano, R., Pezzi, L., D’Alleva, A., Forlani, D., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2508281 · Cited by 27
“Notably, the COAPT trial involved patients without a pre-existing indication for DOAC therapy, who received aspirin and/or clopidogrel for at least 6 months after M-TEER [149].”
MethodPacker, M., & Grayburn, P. A. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.03.016 · Cited by 27
Self-citationPercutaneous interventions for mitral and tricuspid heart valve diseases
Tabata, N., Sugiura, A., Tsujita, K., Nickenig, G., & Sinning, J. (2019) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-019-00610-z · Cited by 27
Slavin, S. D., & Warraich, H. J. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.07.013 · Cited by 27
“38 It is worth noting, however, that even in the intervention arm, the rate of death or hospitalization for HF at 24 months was 48.2%.”
BackgroundInfluentialSex Differences in Epidemiology, Morphology, Mechanisms, and Treatment of Mitral Valve Regurgitation
Tersalvi, G., Gaiero, L., Capriolo, M., Cristoforetti, Y., Salizzoni, S., Senatore, G., Pedrazzini, G. B., & Biasco, L. (2023) · Medicina · doi:10.3390/medicina59061017 · Cited by 27
“This randomized controlled trial from 2018 aimed at assessing safety and effectiveness of TEER with the MitraClip device in patients with heart failure, reduced ejection failure, and secondary MR who remained symptomatic despite the use of guideline-directed medical therapy [51].”
MethodMitral Valve Transcatheter Edge-to-Edge Repair
Lurz, P. C., Schmitz, T., Geisler, T., Hausleiter, J., Eitel, I., Rudolph, V., Lubos, E., von Bardeleben, R. S., Brambilla, N., MARCO, F. D., et al. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.02.022 · Cited by 27
Bannehr, M., Kahn, U., Okamoto, M., Kaneko, H., Hähnel, V., Neuß, M., Haase, M., & Butter, C. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.05.009 · Cited by 27
Lipiecki, J., Kaye, D. M., Witte, K. K., Haude, M., Kapadia, S. R., Sievert, H., Goldberg, S. L., Levy, W. C., & Siminiak, T. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.02.012 · Cited by 27
Self-citationMilitaru, S., Bonnefous, O., Hami, K., Langet, H., Houard, L., Allaire, S., Pouleur, A., Dianis, S. W., This, A., Beauloye, C., et al. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.10.013 · Cited by 27
Transcatheter mitral valve replacement
Enta, Y., & Nakamura, M. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.10.020 · Cited by 27
MitraClip After Failed Surgical Mitral Valve Repair—An International Multicenter Study
Rahhab, Z., Lim, D. S., Little, S. H., Taramasso, M., Kuwata, S., Saccocci, M., Tamburino, C., Grasso, C., Frerker, C., Wißt, T., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019236 · Cited by 27
Self-citationState of the Art: Transcatheter Edge-to-Edge Repair for Complex Mitral Regurgitation
Flint, N., Price, M. J., Little, S. H., Mackensen, G. B., Wunderlich, N. C., Makar, M. M., & Siegel, R. J. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.03.240 · Cited by 27
Liang, Y., Sau, A., Zeidaabadi, B., Barker, J., Patlatzoglou, K., Pastika, L., Sieliwonczyk, E., Whinnett, Z., Peters, N. S., Yu, Z., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf448 · Cited by 26
“2,3 Consequently, it is important to identify patients who, although not currently exhibiting clinically significant VHD, are at high risk of developing it in the future.”
Jneid, H. M., Chikwe, J., Arnold, S. V., Bonow, R. O., Bradley, S. M., Chen, E. P., Diekemper, R. L., Fugar, S. S., Johnston, D. R., Kumbhani, D. J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.006 · Cited by 26
Jneid, H. M., Chikwe, J., Arnold, S. V., Bonow, R. O., Bradley, S. M., Chen, E. P., Diekemper, R. L., Fugar, S. S., Johnston, D. R., Kumbhani, D. J., et al. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000129 · Cited by 25
Conradi, L., Ludwig, S., Sorajja, P., Duncan, A., Bethea, B. T., Dahle, G., Babaliaros, V. C., Guerrero, M. E., Thourani, V. H., Dumonteil, N., et al. (2024) · EuroIntervention · doi:10.4244/eij-d-23-00904 · Cited by 26
Oskouie, S. K., Pandey, A., Sauer, A. J., Greene, S. J., Müllens, W., Khan, M. S., Quinn, K. L., Ho, J. E., Albert, N. M., & Spall, H. G. C. V. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101131 · Cited by 26
Competing Risks in Clinical Trials
Gregson, J., Pocock, S., Anker, S. D., Bhatt, D. L., Packer, M., Stone, G. W., & Zeller, C. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.023 · Cited by 26
Self-citationNew developments in transcatheter therapy of mitral valve disease
Walther, C., Fichtlscherer, S., Holubec, T., Vasa‐Nicotera, M., Arsalan, M., & Walther, T. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.137 · Cited by 26
Maier, R. H., Kasim, A., Zacharias, J., Vale, L. D., Graham, R., Walker, A., Łaskawski, G., Deshpande, R., Goodwin, A. T., Kendall, S. W. H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047676 · Cited by 26
Igata, S., Cotter, B. R., Hang, C. T., Morikawa, N., Strachan, M., Raisinghani, A., Blanchard, D. G., & DeMaria, A. N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018553 · Cited by 26
Claeys, M. J., Debonnaire, P., Bracke, V., Bilotta, G., Shkarpa, N., Vanderheyden, M., Coussement, P. K., Vanderheyden, J., Heyning, C. M. V. D., Cosyns, B., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.062 · Cited by 26
Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure
Song, C., Madhavan, M. V., Lindenfeld, J. M., Abraham, W. T., Kar, S., Lim, D. S., Grayburn, P. A., Kapadia, S. R., Kotinkaduwa, L. N., Mack, M. J., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.11.037 · Cited by 26
Self-citationCatheter-Based Interventions for the Management of Valvular Heart Disease During Pregnancy
Elkayam, U., Bansal, P., & Mehra, A. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100022 · Cited by 26
Orban, M., Rottbauer, W., Williams, M. R., Mahoney, P. D., von Bardeleben, R. S., Price, M. J., Grasso, C., Lurz, P. C., Zamorano, J. L., Asch, F. M., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2770 · Cited by 26
Self-citationMunafò, A. R., Scotti, A., Estévez‐Loureiro, R., Adamo, M., Hernàndez, A. P., Fernández‐Peregrina, E., Gutierrez, L., Taramasso, M., Fam, N., Ho, E. C., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131139 · Cited by 26
Yeo, I., Kim, L. K., Wong, S. C., Cheung, J. W., Itagaki, S., Chikwe, J., & Egorova, N. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.04.006 · Cited by 26
Emerging Technologies for Percutaneous Mitral Valve Repair
Mangieri, A., Laricchia, A., Giannini, F., Gallo, F., Kargoli, F., Ladanyi, A., Testa, L., Colombo, A., & Latib, A. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00161 · Cited by 26
“- The results of the recently published COAPT and MITRA-FR trials have demonstrated that moderate to severe FMR has a clear clinical impact on prognosis, and a successful treatment of FMR with the MitraClip system in selected patients can significantly reduce the rate of rehospitalization, and all-cause mortality at 2…”
ResultRegurgitant Volume/Left Ventricular End-Diastolic Volume Ratio
Namazi, F., van der Bijl, P., Fortuni, F., Mertens, B. J. A., Kamperidis, V., van Wijngaarden, S. E., Stone, G. W., Narula, J., Marsan, N. A., Vahanian, A. S., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.032 · Cited by 26
Self-citationIndividual Patient Data Meta-Analysis of the Effects of the CARILLON® Mitral Contour System
Giallauria, F., Lorenzo, A. D., Parlato, A., Testa, C., Bobbio, E., Vigorito, C., & Coats, A. J. S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13125 · Cited by 26
Medvedofsky, D. A., Pio, S. M., Weissman, N. J., Namazi, F., Delgado, V., Grayburn, P. A., Kar, S., Lim, D. S., Lerakis, S., Zhou, Z., et al. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.04.003 · Cited by 26
Self-citationWorsening heart failure: progress, pitfalls, and perspectives
Fonseca, C., Rui, B., Franco, F., Brenda, M., Pimenta, J., Sarmento, P., Silva‐Cardoso, J., & Brito, D. A. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10497-z · Cited by 26
Iatrogenic atrial septal defect following the MitraClip procedure: A state‐of‐the‐art review
Kadado, A. J., & Islam, A. M. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29149 · Cited by 25
Matsumoto, T., Kubo, S., Izumo, M., Mizuno, S., Shirai, S., & on behalf of the MitraClip Japan PMS Investigators (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0309 · Cited by 25
MitraClip: a review of its current status and future perspectives
Kataoka, A., Watanabe, Y., & Family, T. O.-S. (2022) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-022-00898-4 · Cited by 25
Ducharme, A., Zieroth, S. R., Ahooja, V., Anderson, K., Andrade, J. G., Boivin‐Proulx, L., Ezekowitz, J. A., Howlett, J. G., Lepage, S., Leong, D., et al. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.04.022 · Cited by 25
Lupi, L., Italia, L., Pagnesi, M., Pancaldi, E., Ancona, F., Stella, S., Pezzola, E., Cimino, G., Saccani, N., Ingallina, G., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead103 · Cited by 25
NHC/ SHA 2023 Focused update of the 2019 guidelines for the management of heart failure
Habeeb, W. A., Tash, A. A., Elasfar, A., Almasood, A. S., Bakhsh, A., Elshaer, F., Ayoubi, F. A., Alghalaini, K., Alqaseer, M., Alhussein, M., et al. (2023) · Journal of the Saudi Heart Association · doi:10.37616/2212-5043.1334 · Cited by 25
Minimally Invasive Approaches to Mitral Valve Surgery: Where Are We Now? A Narrative Review
EL‐Andari, R., Watkins, A. R., Fialka, N. M., Kang, J. J. H., Bozso, S. J., Hassanabad, A. F., Vasanthan, V., Adams, C. A., Cook, R., Moon, M. C., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.017 · Cited by 25
Generalizable Approach to Quantifying Guideline-Directed Medical Therapy
Khan, M. S., Chan, P. S., Sherrod, C., Ikemura, N., Sauer, A. J., Jones, P. G., Fonarow, G. C., Butler, J., DeVore, A. D., Lund, L. H., et al. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011164 · Cited by 25
Baldi, C., Citro, R., Silverio, A., Maio, M. D., Rosa, R. D., Bonadies, D., Verolino, G., Esposito, L., Mastrogiovanni, G., Muro, M. R. D., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.055 · Cited by 25
Corpataux, N., Winkel, M., Kassar, M., Brugger, N., Windecker, S., & Praz, F. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01305-1 · Cited by 25
Malik, U. I., Ambrosy, A. P., Ku, I. A., Mishell, J. M., Kar, S., Lim, D. S., Whisenant, B. K., Cohen, D. J., Arnold, S. V., Kotinkaduwa, L. N., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.07.030 · Cited by 25
Self-citationGill, H., Chehab, O., Allen, C. J., Patterson, T., Redwood, S. R., Rajani, R., & Prendergast, B. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2097 · Cited by 25
Lauder, L., Pereira, T., Degenhardt, M. C., Ewen, S., Kulenthiran, S., Coats, A. J. S., Böhm, M., Anker, S. D., da Costa, B. R., & Mahfoud, F. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2360 · Cited by 25
Enriquez-Sarano, M. L., Michelena, H. I., & Grigioni, F. (2019) · Circulation · doi:10.1161/circulationaha.118.038207 · Cited by 25
Reed, S. D., Fairchild, A. O., Johnson, F. R., Gonzalez, J. M., Mentz, R. J., Krucoff, M. W., & Vemulapalli, S. (2019) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.119.008051 · Cited by 24
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.